<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Caradja, G.M.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Particularităţi ale tratamentului conservativ la pacienţii cu guşă toxică</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2011</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-1719</relatedIdentifier>
<dates>
<date dateType='Issued'>2011-06-01</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'>Thyroid antibodies after surgical treatment in patients with diffuse toxic goiter
The study covered 102 patients with diffuse toxic goiter (DTG) and 24 patients with
mono-, polinodular toxic goiter (NTG). A permanent remission occurred in 49% of the patients
with DTG and in 28% of the patients with NTG receiving thyrostatic therapy.
The risc factors of recurrent toxic goiter included young age (under 35 years), a large size
of goiter (more than 30 ml), and the absence of a decrease or an increase in the volume of the
thyroid during therapy. Recurrent toxic goiter developed as a rule within a year after thyrostatic
treatment - in 50% of the patients with DTG and NTG.</description>
<description xml:lang='ro' descriptionType='Abstract'>Studiul cuprinde 102 pacienţi cu guşă difuză toxică (GDT) şi 24 pacienţi cu guşă uni-,
polinodulară toxică (GNT). Remisia permanentă s-a dezvoltat la 49% pacienţi cu GDT şi la 28%
pacienţi cu GNT care au primit tratament tireostatic.
Factorii de risc ai recidivării guşii toxice includ vârsta tânără (sub 35 ani), dimensiune
mare a guşii (mai mare de 30 ml) şi lipsa micşorării sau creşterea volumului tiroidei pe fondal de
tratament. Recidivarea guşii toxice mai des are loc pe parcursul primului an de la tratamentul
tireostatic, - la 50% dintre pacienţii cu GDT şi GNT.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>